RMR Wealth Builders’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
CGH
RMR Wealth Builders's GILD Position: Q2 2026 in Review
RMR Wealth Builders increased its Gilead Sciences (GILD) stake by 182% in Q2 2026, buying an estimated $3.34M and bringing the position to 39,220 shares worth $4.96M. The position accounts for 0.31% of the portfolio, ranked #52.
RMR Wealth Builders first reported a position in GILD in Q4 2019 and has held it in 21 quarters since. 734 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- RMR Wealth Builders held 39,220 shares of Gilead Sciences worth $4.96M as of Q2 2026.
- RMR Wealth Builders bought 25,336 Gilead Sciences shares in Q2 2026, an estimated $3.34M.
- Gilead Sciences made up 0.31% of RMR Wealth Builders's portfolio in Q2 2026, its #52 holding.
- RMR Wealth Builders first reported a position in Gilead Sciences in Q4 2019 and has held it in 21 quarters since.
- 734 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on RMR Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.